Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Well also explore any environmental factors that may be influencing your weight
It is indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is NOT due to: References Mechanism of Action 1-2 Bremelanotide, a MCR agonist, non-selectively works on several receptor subtypes MC1R-MC5R in the central nervous system
Who Qualifies Under FDA-Approved Labeling The FDA label for Wegovy specifies use in adults with an initial BMI of 30 kg/m or above, or 27 kg/m or above in the presence of at least one weight-related condition (hypertension, type 2 diabetes, or dyslipidemia), as an adjunct to reduced-calorie diet and increased physical activity
One pharmacist mimed that it stings, & he was right
US$ 24.91
US$ 28.84
US$ 27.71
